Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jansen, G. A.
Right arrow Articles by Wanders, R. J.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jansen, G. A.
Right arrow Articles by Wanders, R. J.A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2000, Vol. 9, No. 8 1195-1200
© 2000 Oxford University Press

Human phytanoyl-CoA hydroxylase: resolution of the gene structure and the molecular basis of Refsum’s disease

Gerbert A. Jansen1, Eveline M. Hogenhout2, Sacha Ferdinandusse2, Hans R. Waterham1, Rob Ofman2, Cornelis Jakobs3, Ola H. Skjeldal4 and Ronald J.A. Wanders1,2,+

University of Amsterdam, Academic Medical Centre, Departments of 1Pediatrics (Emma Children’s Hospital) and 2Clinical Chemistry, Laboratory for Genetic Metabolic Diseases (Room F0-224), PO Box 22700, 1100 DE Amsterdam, The Netherlands, 3Free University Hospital, Department of Clinical Chemistry, Metabolic Unit, Amsterdam, The Netherlands and 4Department of Pediatrics, Institute of Clinical Biochemistry, Rikshospitalet, Oslo, Norway

Refsum’s disease (RD) is an inherited neurological syndrome biochemically characterized by the accumulation of phytanic acid in plasma and tissues. Patients with RD are unable to degrade phytanic acid due to a deficient activity of phytanoyl-CoA hydroxyl­ase (PhyH), a peroxisomal enzyme catalysing the first step of phytanic acid {alpha}-oxidation. To enable mutation analysis of RD at the genome level, we have elucidated the genomic organization of the PHYH gene. The gene is ~21 kb and contains nine exons and eight introns. Mutation analysis of PHYH cDNA from 22 patients with RD revealed 14 different missense mutations, a 3 bp insertion, and a 1 bp deletion, which were all confirmed at the genome level. A 111 bp deletion identified in the PHYH cDNA of several patients with RD was due to either one of two different mutations in the same splice acceptor site, which result in skipping of exon 3. Six mutations, including a large in-frame deletion and five missense mutations, were expressed in the yeast Saccharomyces cerevisiae to study their effect on PhyH activity. The results showed that all these mutations lead to an enzymatically inactive PhyH protein.

+ To whom correspondence should be addressed. Tel: +31 20 5664197; Fax: +31 20 6962596; Email: wanders@amc.uva.nl


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. A. McDonough, K. L. Kavanagh, D. Butler, T. Searls, U. Oppermann, and C. J. Schofield
Structure of Human Phytanoyl-CoA 2-Hydroxylase Identifies Molecular Mechanisms of Refsum Disease
J. Biol. Chem., December 9, 2005; 280(49): 41101 - 41110.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. Searls, D. Butler, W. Chien, M. Mukherji, M. D. Lloyd, and C. J. Schofield
Studies on the specificity of unprocessed and mature forms of phytanoyl-CoA 2-hydroxylase and mutation of the iron binding ligands
J. Lipid Res., August 1, 2005; 46(8): 1660 - 1667.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
V. Foulon, S. Asselberghs, W. Geens, G. P. Mannaerts, M. Casteels, and P. P. Van Veldhoven
Further studies on the substrate spectrum of phytanoyl-CoA hydroxylase: implications for Refsum disease?
J. Lipid Res., December 1, 2003; 44(12): 2349 - 2355.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. Brites, A. M. Motley, P. Gressens, P. A.W. Mooyer, I. Ploegaert, V. Everts, P. Evrard, P. Carmeliet, M. Dewerchin, L. Schoonjans, et al.
Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata
Hum. Mol. Genet., September 15, 2003; 12(18): 2255 - 2267.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
Suppression of the ELO-2 FA Elongation Activity Results in Alterations of the Fatty Acid Composition and Multiple Physiological Defects, Including Abnormal Ultradian Rhythms, in Caenorhabditis elegans
Genetics, January 1, 2003; 163(1): 159 - 169.



Home page
Hum Mol GenetHome page
M. Mukherji, W. Chien, N. J. Kershaw, I. J. Clifton, C. J. Schofield, A. S. Wierzbicki, and M. D. Lloyd
Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease
Hum. Mol. Genet., September 1, 2001; 10(18): 1971 - 1982.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. W. Bauer, F. Rouan, B. Kofler, G. A. Rezniczek, I. Kornacker, W. Muss, R. Hametner, A. Klausegger, A. Huber, G. Pohla-Gubo, et al.
A Compound Heterozygous One Amino-Acid Insertion/Nonsense Mutation in the Plectin Gene Causes Epidermolysis Bullosa Simplex with Plectin Deficiency
Am. J. Pathol., February 1, 2001; 158(2): 617 - 625.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. M. Vaz, R. Ofman, K. Westinga, J. W. Back, and R. J. A. Wanders
Molecular and Biochemical Characterization of Rat epsilon -N-Trimethyllysine Hydroxylase, the First Enzyme of Carnitine Biosynthesis
J. Biol. Chem., August 31, 2001; 276(36): 33512 - 33517.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.